CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

REGENXBIO Announces Proposed Public Offering of Common Stock

Neutral
AI Analysis

Summary

REGENXBIO Inc. announced a proposed underwritten public offering of $100 million in common stock, subject to market conditions.

Importance:6/10
Sentiment:
0.00
public offeringcapital raisecommon stock
Related Companies

Read the original article

Published by PR Newswire Biotech on July 16, 2026 8:26 PM

Read Original